trending Market Intelligence /marketintelligence/en/news-insights/trending/y-f5rwkVJxe8XP-At12xRg2 content
Log in to other products

Login to Market Intelligence Platform

 /

Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

HealthEquity issues fiscal 2020 outlook

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report

Fintech

Fintech Funding Flows To Insurtech In February

Lemonade Growing Premiums Faster Than Esurance's Homeowners Business Did


HealthEquity issues fiscal 2020 outlook

HealthEquity Inc. has issued guidance for the fiscal year ending Jan. 31, 2020.

The company anticipates revenue to range from $333 million to $339 million; net income to be between $58 million and $62 million, or between 89 cents and 95 cents per share; non-GAAP net income to range from $80 million to $84 million, or $1.23 to $1.29 per share; and adjusted EBITDA to be between $133 million and $138 million.

For the fiscal year ended Jan. 31, 2019, HealthEquity reported revenue of $287.2 million; net income of $73.9 million, or $1.17 per share; non-GAAP net income of $76 million, or $1.19 per share; and adjusted EBITDA of $118.4 million.

In the fiscal year ended Jan. 31, 2018, the company reported net income of $47.4 million, or 77 cents per share.

HealthEquity reported fiscal fourth-quarter net income of $13.1 million, or 21 cents per share, compared to $5.9 million, or 9 cents per share, in the year-ago period. On a non-GAAP basis, it recorded net income of $17 million, or 27 cents per share.

The S&P Global Market Intelligence consensus normalized EPS estimates for fiscal fourth quarter and fiscal year 2019 were 22 cents and $1.16, respectively.